2008 News

New Report: Nearly 400 Medicines in New Jersey’s Research Pipeline for Leading Causes of Death

Bridgewater, NJ, November 18, 2008 — The HealthCare Institute of New Jersey (HINJ) today released a new report on the next generation of medicines in the state′s biopharmaceutical research pipelines that offer hope to millions of patients. Read more


24th Annual NJ Alliance for Action Construction Forecast: NJ’s Biopharmaceutical and Medical Technology Industry Continues to Lead State in Capital Construction Expenditures

  • $3.37 billion in construction spending over next 2 years;
  • $1.73 billion in 2009
  • $1.63 billion in 2010

Trenton, NJ, November 6, 2008 — For the seventh straight year, New Jersey’s biopharmaceutical and medical technology industry lead the way in private sector planned construction, reporting $3.37 billion in construction expenditures over the next two years.  These data were reported today at the 24th Annual Construction Forecast Seminar, sponsored by the New Jersey Alliance for Action. Read more


Congressman Frelinghuysen Joins NJ Pharmaceutical & Medical Technology Industry in Delivering 1,000 Books to Dover’s Children

Bridgewater, NJ, October 15, 2008 — Congressman Rodney Frelinghuysen (R-11) today joined with New Jersey′s pharmaceutical and medical technology industry in delivering 1,000 new children′s books to the Zufall Health Center, 17 S. Warren St. in Dover to distribute to their youngest patients.  The center participates in Reach Out and Read, a national children′s literacy program in which doctors give books to infants, toddlers and preschoolers at check-ups and advise their parents about the importance of reading to their children. Read more


New Report: NJ Life Science Sector Remains Profitable But Job Growth Slows

Collaborative Report from HINJ and Deloitte Affirms Influence of Pharmaceutical, Medical Technology Industry to State Economy; Business Challenges Lie Ahead 

Bridgewater, NJ, August 18, 2008 — The life sciences industry in New Jersey demonstrated stable growth in 2007, according to a new research study released today.  However, the outlook for future growth for the state′s biopharmaceutical and medical technology companies is being tempered by on-going challenges to the industry′s global business model. Read more


Women’s Health Care Summit on Ovarian Cancer Aims for Greater Public Awareness of Women’s Health Issues

Ovarian Cancer Experts Focus on Prevention and Treatment 

Bridgewater, NJ, April 14, 2008 — The HealthCare Institute New Jersey (HINJ) today hosted a Women’s Health Care Summit on Ovarian Cancer at the Morris Museum in Morristown, which featured Congressman Rodney Frelinghuysen and a host of ovarian cancer experts. Read more


Coalition Claims Victory in Fight for Patient Safety

New Jersey Is First State to Adopt ‘Adverse Events’ Reporting Regulations

Bridgewater, NJ, March 29, 2008 — On March 3, 2008, New Jersey became the first state in the nation to track adverse events involving the use of reprocessed single-use medical devices.  Regulations adopted by the New Jersey Department of Health and Senior Services, 40 N.J.R 1049(a), will require hospitals, surgical centers, and long term care facilities to report to the Department that an adverse event involves a reprocessed single-use device. Read more


Password Reset

Please enter your e-mail address. You will receive a new password via e-mail.